Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rho-associated protein kinase (ROCK) is a serine/threonine-specific protein kinase that acts as a major downstream effector of the small GTPase RhoA. It plays a central role in regulating cytoskeletal dynamics, cell shape, motility, contraction, polarity, division, and gene expression. Dysregulation or overactivation of the Rho/ROCK pathway has been implicated in various diseases such as hypertension, glaucoma, and neurodegeneration. There are two main isoforms in mammals: ROCK1 and ROCK2.
Pharmacological inhibition of ROCK, targeting either the ATP binding site or allosteric sites on one/both isoforms.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho-associated protein kinase.